These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21993571)

  • 41. Expression of the human phosphatases of regenerating liver (PRLs) in colonic adenocarcinoma and its correlation with lymph node metastasis.
    Wang Y; Li ZF; He J; Li YL; Zhu GB; Zhang LH; Li YL
    Int J Colorectal Dis; 2007 Oct; 22(10):1179-84. PubMed ID: 17440740
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells.
    Stephens B; Han H; Hostetter G; Demeure MJ; Von Hoff DD
    Mol Cancer Ther; 2008 Jan; 7(1):202-10. PubMed ID: 18187808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting phosphatases of regenerating liver (PRLs) in cancer.
    Wei M; Korotkov KV; Blackburn JS
    Pharmacol Ther; 2018 Oct; 190():128-138. PubMed ID: 29859177
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphatase-independent role of phosphatase of regenerating liver in cancer progression.
    Funato Y; Hashizume O; Miki H
    Cancer Sci; 2023 Jan; 114(1):25-33. PubMed ID: 36285487
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Expression and its relationship of PRL-3 and RhoC in non-small cell lung cancer].
    Zhang P; Zhang Z; Li X; Lei J; Su K; Li X; Wang X
    Zhongguo Fei Ai Za Zhi; 2010 Jun; 13(6):598-601. PubMed ID: 20681446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting PRL phosphatases in hematological malignancies.
    Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
    Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulatory mechanisms of phosphatase of regenerating liver (PRL)-3.
    Rubio T; Köhn M
    Biochem Soc Trans; 2016 Oct; 44(5):1305-1312. PubMed ID: 27911713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PRL phosphatases as potential molecular targets in cancer.
    Stephens BJ; Han H; Gokhale V; Von Hoff DD
    Mol Cancer Ther; 2005 Nov; 4(11):1653-61. PubMed ID: 16275986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural Basis of the Oncogenic Interaction of Phosphatase PRL-1 with the Magnesium Transporter CNNM2.
    Giménez-Mascarell P; Oyenarte I; Hardy S; Breiderhoff T; Stuiver M; Kostantin E; Diercks T; Pey AL; Ereño-Orbea J; Martínez-Chantar ML; Khalaf-Nazzal R; Claverie-Martin F; Müller D; Tremblay ML; Martínez-Cruz LA
    J Biol Chem; 2017 Jan; 292(3):786-801. PubMed ID: 27899452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Pharmacological Inhibition of the Catalytic Activity of Phosphatases of Regenerating Liver in Early T Cell Receptor Signaling Dynamics and IL-2 Production.
    Aguilar-Sopeña O; Hernández-Pérez S; Alegre-Gómez S; Castro-Sánchez P; Iglesias-Ceacero A; Lazo JS; Roda-Navarro P
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32260565
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice.
    Guo K; Tang JP; Tan CP; Wang H; Zeng Q
    Cancer Biol Ther; 2008 May; 7(5):750-7. PubMed ID: 18364570
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The double lives of phosphatases of regenerating liver: A structural view of their catalytic and noncatalytic activities.
    Gehring K; Kozlov G; Yang M; Fakih R
    J Biol Chem; 2022 Jan; 298(1):101471. PubMed ID: 34890645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphatase of Regenerating Liver-1 Regulates Wing Vein Formation through TGF-β Pathway in
    Zheng H; Lou Z; Yuan X; Wu H; Yang X; Xi Y
    Front Biosci (Landmark Ed); 2022 Jun; 27(6):176. PubMed ID: 35748252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Burst kinetics and CNNM binding are evolutionarily conserved properties of phosphatases of regenerating liver.
    Fakih R; Goldstein RH; Kozlov G; Gehring K
    J Biol Chem; 2023 Apr; 299(4):103055. PubMed ID: 36822330
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Localizing PRL-2 expression and determining the effects of dietary Mg(2+) on expression levels.
    Gungabeesoon J; Tremblay ML; Uetani N
    Histochem Cell Biol; 2016 Jul; 146(1):99-111. PubMed ID: 27015884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration.
    Sun JP; Luo Y; Yu X; Wang WQ; Zhou B; Liang F; Zhang ZY
    J Biol Chem; 2007 Sep; 282(39):29043-29051. PubMed ID: 17656357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling.
    Liu H; Li X; Shi Y; Ye Z; Cheng X
    Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphatase of regenerating liver: a novel target for cancer therapy.
    Campbell AM; Zhang ZY
    Expert Opin Ther Targets; 2014 May; 18(5):555-69. PubMed ID: 24579927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phosphatases of regenerating liver are key regulators of metabolism in cancer cells - role of Serine/Glycine metabolism.
    Abdollahi P; Vandsemb EN; Børset M
    Curr Opin Clin Nutr Metab Care; 2022 Jan; 25(1):50-55. PubMed ID: 34725313
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of PRL-2·CNNM3 Protein Complex Formation Decreases Breast Cancer Proliferation and Tumor Growth.
    Kostantin E; Hardy S; Valinsky WC; Kompatscher A; de Baaij JH; Zolotarov Y; Landry M; Uetani N; Martínez-Cruz LA; Hoenderop JG; Shrier A; Tremblay ML
    J Biol Chem; 2016 May; 291(20):10716-25. PubMed ID: 26969161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.